EBERT; BENJAMIN LEVINE

Patent Applications and Registrations

Patent applications and USPTO patent grants for EBERT; BENJAMIN LEVINE.The latest application filed is for "methods of characterizing resistance to modulators of cereblon".

Company Profile

6.6.16

EBERT; BENJAMIN LEVINE - BOSTON MA
Ebert; Benjamin Levine - Brookline MA
EBERT; BENJAMIN LEVINE - CAMBRIDGE MA US
Ebert; Benjamin Levine - Brooklin MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Characterizing Resistance To Modulators Of Cereblon App 20220251651 - EBERT; BENJAMIN LEVINE ; et al.	2022-08-11
Methods Of Identifying And Treating A Person Having A Predisposition To Or Afflicted With A Cardiometabolic Disease App 20220170100 - Ebert; Benjamin Levine ; et al.	2022-06-02
Methods Of Identifying Drug-modulated Polypeptide Targets For Degradation App 20220017938 - MIKKELSEN; TARJEI ; et al.	2022-01-20
Methods of identifying a polypeptide target for degradation by a modulator of CRBN Grant 11,168,345 - Mikkelsen , et al. November 9, 2	2021-11-09
Mutation signatures for predicting the survivability of myelodysplastic syndrome subjects Grant 10,711,308 - Bejar , et al.	2020-07-14
Knock-in Rodent Comprising A Mutation In An Endogenous Crbn Locus And Methods Of Use Thereof App 20190274292 - EBERT; BENJAMIN LEVINE ; et al.	2019-09-12
IMiD screening methods IMiD-sensitive cells with mutant CRBN Grant 10,334,829 - Ebert , et al.	2019-07-02
Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and Compositions App 20190106710 - Zhang; Feng ; et al.	2019-04-11
Methods Of Identifying Drug-modulated Polypeptide Targets For Degradation App 20190071731 - MIKKELSEN; TARJEI ; et al.	2019-03-07
Knock-in Rodent Comprising A Mutation In An Endogenous Crbn Locus And Methods Of Use Thereof App 20180343839 - EBERT; BENJAMIN LEVINE ; et al.	2018-12-06
Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof Grant 9,974,289 - Ebert , et al. May 22, 2	2018-05-22
Method Of Identifying And Treating A Person Having A Predisposition To Or Afflicted With A Cardiometabolic Disease App 20180010185 - Ebert; Benjamin Levine ; et al.	2018-01-11
Knock-in Rodent Comprising A Mutation In An Endogenous Crbn Locus And Methods Of Use Thereof App 20160338326 - EBERT; BENJAMIN LEVINE ; et al.	2016-11-24
Compositions And Methods For Selecting A Treatment For B-cell Neoplasias App 20160282354 - EBERT; BENJAMIN LEVINE ; et al.	2016-09-29
Oncogenic Models Based On Delivery And Use Of The Crispr-cas Systems, Vectors And Compositions App 20160168594 - Zhang; Feng ; et al.	2016-06-16
Mutation Signatures for Predicting the Survivability of Myelodysplastic Syndrome Subjects App 20140127690 - Bejar; Rafael ; et al.	2014-05-08
Lsc And Hsc Signatures For Predicting Survival Of Patients Having Hematological Cancer App 20120237488 - Dick; John ; et al.	2012-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.